Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aminoacidopathies
aminoacidurias
amyloidosis
autonomic dysfunction
Bence Jones protein
bone marrow biopsy
bone survey
bone survey, metastatic
CAT scan
CAT scan, abnormal
CAT scan, base of skull
CAT scan, contrast enhanced
cerebrospinal fluid, gammaglobulin of
Clinical Pathologic Conference(C.P.C.)
cranial nerve palsies
cranial neuropathy
cranial neuropathy, multiple
cystinuria
diplopia
electrophoretic pattern, serum
electrophoretic pattern, urine
facial nerve palsy
facial pain
immunoelectrophoresis, serum
Lhermitte's sign
medial rectus palsy
monoclonal gammopathy
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, skull bone changes
multiple myeloma
multiple sclerosis, differential diagnosis of
myeloma, osteosclerotic
nerve biopsy
neuropathy
neuropathy, peripheral
paraparesis, spastic
plasma cell myeloma, CNS involvement associated with
plasmacytoma
pleocytosis of cerebrospinal fluid
prognosis
proteinuria
renal stones
seizure
third nerve palsy
urinary incontinence
visual acuity, decreased
visual acuity, decreased, monocular
visual loss, slow-unilateral
Showing articles 500 to 550 of 979 << Previous Next >>

Clincopath Conference, Endogenous Endophthalmitis Due to Aspergillus Niger
NEJM 363:1749-1758, Case 33-2010, 2010

Predictors of Neurologic Outcome in Hypothermia After Cardiac Arrest
Ann Neurol 68:907-914, Fugate,J.E.,et al, 2010

Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types
AJNR 31:541-548, 390, Vrenken,H.,et al, 2010

Clincopath Conf, Pheochromocytoma
NEJM 362:1815-1823, Case 14-2010, 2010

Childhood Posterior Circulation Arterial Ischemic Stroke
Stroke 41:2201-2209, Mackay,M.T.,et al, 2010

Increased Tissue Damage and Lesion Volumes in African Americans with Multiple Sclerosis
Neurol 74:538-544,532, Weinstock-Guttman,B.,et al, 2010

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010

Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA
Stroke 40:3834-3840, Smith,W.,et al, 2009

The Microbleed Anatomical Rating Scale (MARS): Reliability of a Tool to Map Brain Microbleeds
Neurol 73:1759-1766, Gregoire,S.,et al, 2009

Fast-In, Fast-Out
Lancet 373:1398, Hefele,B.,et al, 2009

A 28-Year-Old Pregnant Woman with Encephalopathy
Neurol 73:e74-e79, Grinspan,Z.,et al, 2009

Exclusive Breastfeeding and the Risk of Postpartum Relapses in Women with Multiple Sclerosis
Arch Neurol 66:958-963, Langer-Gould,A.,et al, 2009

Diagnostic Usefulness of the ABCD Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events: The North Dublin TIA Study
Stroke 40:3449-3454, Sheehan,O.,et al, 2009

Real-Life Impact of Early Interferon� Therapy in Relapsing Multiple Sclerosis
Ann Neurol 66:513-520, Trojano,M.,et al, 2009

Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009

Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

MRI Features of Benign Multiple Sclerosis: Toward a New Definition of This Disease Phenotype
Neurol 72:1693-1701, Rovaris,M.,et al, 2009

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol 66:601-609, Seewann,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Hippocampal Lesion Patterns in Acute Posterior Cerebral Artery Stroke: Clinical and MRI Findings
Stroke 40:2042-2045, Szabo,K.,et al, 2009

Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009

Clinicopath Conf., Atypical Hemolytic-Uremic Syndrome
NEJM 361:389-400, Case 23-2009, 2009

Relapse Management in Multiple Sclerosis
The Neurologist 15:1-5, Thrower,B.W., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Clinicopath Conf, Neurosarcoidosis
NEJM 360:802-809, Case 6-2009, 2009

Invited Article: An MRI-Based Approach to the Diagnosis of White Matter Disorders
Neurol 72:750-759, Shiffmann,R. &van der Knaap,M.S., 2009

Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009

Posterior Cerebral Artery Infarction: Diffusion-Weighted MRI Analysis of 205 Patients
Cerebrovasc Dis 28:298-305, Lee,E.,et al, 2009

Ischemic Stroke of the Cortical "Hand Knob" Area: Stroke Mechanisms and Prognosis
J Neurol 256:1146-1151, Peters, N.,et al, 2009

Multiple Bilateral Non-Hemorrhagic Cerebral Infarctions Associated with Microscopic Polyangiitis
Clin Neurol Neurosurg 111:904-906, Ku, B. & Shin, H., 2009

Microscopic Polyangiitis Presenting with Capsular Warning Syndrome and Subsequent Stroke
J Neurol Sci 277:174-175, Tang, C.,et al, 2009

Non-Infectious Endocarditis in a Patient with cANCA-associated Small Vessel Vasculitis
Rheumatology 48:592-594, Horino, T.,et al, 2009

The Leptomeningeal "Ivy Sign" on Fluid-Attenuated Inversion Recovery MR Imaging in Moyamoya Disease: A Sign of Decreased Cerebral Vascular Reserve?
AJNR 30:930-935, Mori,N.,et al, 2009

Ethylene Glycol Toxicity: Chemistry, Pathogenesis, and Imaging
Radiology Case Reports 3, Moore, M.M.,et al, 2008

Differential Diagnosis of Restricted Diffusion Confined to the Cerebral Cortex
Clin Radiol 63:1245-1253, Sheerin,F.,et al, 2008

Stroke Syndrome Secondary to Hypercoagulability of Lung Cancer
Commun Oncol 5:595-596, Lim, B. & Henry, D.H., 2008

Optimal Diffusion-Weighted Imaging Protocol for Lesion Detection in Transient Global Amnesia
AJNR 29:1324-1328, Weon, Y.C.,et al, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Frequency and Topographic Distribution of Brain Lesions in Pediatric Cerebral Venous Thrombosis
AJNR 29:1961-1965, Teksam,M.,et al, 2008

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study
Lancet 372:1463-1472, Kappos,L.,et al, 2008

Multiple Sclerosis
Lancet 372:1502-1517, Compston,A. &Coles,A., 2008

Combining Beta Interferon and Atorvastatin May Increase Disease Activity in Multiple Sclerosis
Neurol 71:1390-1395,1386, Birnbaum,G.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Arch Neuol 65:1313-1318, Claassen,D.O.,et al, 2008

Racial Differences in Microbleed Prevalence in Primary Intracerebral Hemorrhage
Neurol 71:1176-1182, Copenhaver,B.R.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008



Showing articles 500 to 550 of 979 << Previous Next >>